1. P185 META–ANALYSIS OF PLACEBO–CONTROLLED TRIALS OF LEVOSIMENDAN IN ACUTE MYOCARDIAL INFARCTION. (18th May 2022) Authors: Tumminello, G; Cereda, A; Laricchia, A; Carlà, M; Conconi, B; Barbieri, L; Lucreziotti, S; Carugo, S Journal: European heart journal supplements Issue: Volume 24(2022)Supplement C Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: A multicenter and multiethnic study. Issue 1 (1st February 2015) Authors: Rutten, B; Maseri, A; Cianflone, D; Laricchia, A; Cristell, N A; Durante, A; Spartera, M; Ancona, F; Limite, L; Hu, D; Li, H; Uren, N G; de Groot, P G; Mannucci, P M; Roest, M Journal: European heart journal Issue: Volume 4:Issue 1(2015:Feb.) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: A multicenter and multiethnic study. Issue 1 (February 2015) Authors: Rutten, B; Maseri, A; Cianflone, D; Laricchia, A; Cristell, NA; Durante, A; Spartera, M; Ancona, F; Limite, L; Hu, D; Li, H; Uren, NG; de Groot, PG; Mannucci, PM; Roest, M Journal: European heart journal Issue: Volume 4:Issue 1(2015:Feb.) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗